Main» Health» Reuters Health eLine»

Pfizer's Sutent improves survival in cancer study

1.01.1970 / Reuters Health eLine

ORLANDO, Florida (Reuters) - Pfizer Inc.'s experimental drug Sutent improved survival and reduced tumor growth in patients with a type of stomach cancer, according to a pivotal-stage trial the company unveiled this weekend.

Read Full News >>

Similiar Reuters Health eLine News:

Breast cancer protein doesn't help select therapy
Vibrations, repeat motion tied to shoulder injury
Sugary drinks raise risk of gout in men
Toxoplasmosis may raise schizophrenia risk
Half of all hospital patients at clot risk: study
Hospital stays frequently endanger newborns: study
Figures suggest new increase in U.S. Army suicides
Tamiflu-resistant flu reported in U.S. and Canada
Ipods show no effects on heart pacemakers
Vitamin D deficiency tied to higher blood pressure
Inexperienced carpenters at risk of falls
Folate in 2nd trimester helps prevent preeclampsia
Women on methadone may safely breast-feed
Newer psychosis drug cuts risk of movement problem
Weight loss drug safely used in high-risk patients
Oral penicillin allergy test may be safe for some
Prostate surgery approach may reduce incontinence
Fewer trips outside neighborhood tied to frailty
Obesity drug prescriptions soar in Britain
US warns of suicidal actions with epilepsy drugs
Epsom salt can prevent cerebral palsy: U.S. study
Infant study casts doubt on vaccine-autism link
Blacks more apt to leave hospice for treatment
Parents' birthweight tied to prematurity risk
Most heart attack survivors skip cardiac rehab
Folate 1 year before conception cuts early birth risk
Kidney injuries in football rare, can be serious
No-needle anesthetic method useful for vasectomy
Lung cancer surgery improves quality of life
Heart rate predicts survival after heart attack
Avandia study results leaked to drug maker
Periodontal disease associated with kidney disease
Metabolic syndrome on the rise among obese teens
Stress syndrome adds risk to vets with head injury
Testosterone seen unrelated to prostate cancer risk
Signs of emphysema may develop early in pot smokers
Feeling fat may be worse for you than being fat
Enzyme may provide treatment for gluten intolerance
Weight loss by diet or exercise benefits heart
Antioxidants more likely to raise cancer risk
More heart transplants needed for best results
Genes affect risk from smoke in CF patients
Breast cancer care linked with surgeon factors
Salmonella from pet turtles sickens 103 in '07
High-protein diet linked with sustained weight loss
Bisexuality not a phase for most women
Mouth burns during tonsillectomy underreported
Personality doesn't affect breast cancer risk
Genes plus neglect may raise depression risk
Hospitals vary widely in determining brain death

Top: Pfizer's Sutent improves survival in cancer study

News Directory: Pfizer's Sutent improves survival in cancer study

Main» Health» Reuters Health eLine»

Pfizer's Sutent improves survival in cancer study

1.01.1970 / Reuters Health eLine

Apple

Arts & Stage

Business

Computers

Enterprise

Entertainment

Fashion

Games

Health

Industry

Internet

Linux

Others

Science

Sports

Technology

World News

Affiliates: